ViewPoint Therapeutics Competitors and Similar CompaniesClear all
Molecular Partners's competitors and similar companies include Y-mAbs Therapeutics.
 Molecular Partners Molecular Partners is a company that develops biopharmaceutical products for serious diseases. |  Y-mAbs Therapeutics Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets. | |
Founding Date | Founding Date 2004 | Founding Date 2014 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Zürich-Schlieren, CH HQ Cambridge, US Concord, US | Locations New York, US HQ Copenhagen, DK Nutley, US |
Employees | Employees 158 | Employees 3239% increase |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $87.7m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods $15m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit $72.7m (FY, 2024) |
Net income | Net income (CHF61.7m) (FY, 2025) | Net income ($29.7m) (FY, 2024) |
For sources of this data, please see the company profile
View Company Profiles
Y-mAbs Therapeutics
HQ
New York, US
Employees
32↑ 39% increase
Y-mAbs Therapeutics is a clinical-stage biopharmaceutical company developing novel antibody therapeutics for oncology targets.
View company